share_log

Clarus Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner THOMAS MCNERNEY & PARTNERS LP

Apr 25, 2022 17:17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more